Stoke Therapeutics (STOK) Share-based Compensation (2018 - 2026)
Stoke Therapeutics' Share-based Compensation came in at $10.8 million for Q2 2026, up 42.2% from $7.6 million a year earlier and up 23.4% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Share-based Compensation (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Stoke Therapeutics reported Share-based Compensation of $37.44 million, up 29.0% year-over-year; for FY2025, it was $32.24 million, up 17.2% from FY2024.
- Share-based Compensation has increased in each of the last seven years, with a five-year compound annual growth rate of 40.9% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $27.5 million in FY2024 (+8.7%), $25.3 million in FY2023 (+10.5%), $22.9 million in FY2022 (+38.8%) and $16.5 million in FY2021 (+184.5%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q2 2018.
- Year-over-year, Share-based Compensation has increased for nine consecutive quarters, with growth averaging 21.9% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 193.8%), and the weakest in Q1 2024 (a decline of 8.1%).
- Business Quant data shows STOK's Share-based Compensation at $8.75 million (Q1 2026), $9.85 million (Q4 2025) and $8.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Stoke Therapeutics | 1.90 Bn | 658.22 Mn | - | 11.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.03 Mn |
| Jun 30, 2026 | 10.80 Mn |
| Mar 31, 2026 | 8.75 Mn |
| Dec 31, 2025 | 9.85 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 7.17 Mn |
| Sep 30, 2024 | 7.49 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 6.76 Mn |
| Mar 31, 2023 | 5.89 Mn |
| Dec 31, 2022 | 5.84 Mn |
| Sep 30, 2022 | 5.93 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 4.74 Mn |
API Access
Stoke Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();